Xueying J. Cui
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment outcomes and prognostic analysis of elderly patients with extranodal natural killer/T-cell lymphoma, nasal type: a retrospective analysis.
Journal: Leukemia & lymphoma
Published: July 21, 2020
Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study.
Journal: Cancer biology & medicine
Published: April 27, 2020
Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study.
Journal: Leukemia & lymphoma
Published: September 14, 2019
Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.
Journal: International journal of hematology
Published: December 15, 2016
The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma
Journal: Zhonghua nei ke za zhi
Published: April 25, 2015
Clinical significance of peripheral blood CD4+CD25+ regulatory T cell in patients with extranodal NK/T cell lymphoma, nasal type
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 24, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026